Cargando…

Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease

BACKGROUND/AIMS: Nonobese metabolic dysfunction-associated fatty liver disease (MAFLD) is paradoxically associated with improved metabolic and pathological features at diagnosis but similar cardiovascular diseases (CVD) prognosis to obese MAFLD. We aimed to utilize the metabolomics to identify the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Congxiang, Xu, Lishu, Lei, Pingguang, Wang, Wei, Feng, Shiting, Ye, Junzhao, Zhong, Bihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830861/ https://www.ncbi.nlm.nih.gov/pubmed/36624524 http://dx.doi.org/10.1186/s12967-022-03760-6

Ejemplares similares

The Ability of Lipoprotein (a) Level to Predict Early Carotid Atherosclerosis Is Impaired in Patients With Advanced Liver Fibrosis Related to Metabolic-Associated Fatty Liver Disease
por: Wu, Tingfeng, et al.
Publicado: (2022)

Lipid-Lowering Responses to Dyslipidemia Determine the Efficacy on Liver Enzymes in Metabolic Dysfunction-Associated Fatty Liver Disease with Hepatic Injuries: A Prospective Cohort Study
por: Liao, Xianhua, et al.
Publicado: (2022)

Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis
por: Li, Fuxi, et al.
Publicado: (2021)

Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection
por: Luo, Ling, et al.
Publicado: (2022)

Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease
por: Wu, Tingfeng, et al.
Publicado: (2021)

Discrepancies between Nonalcoholic and Metabolic-associated Fatty Liver Disease by Multiple Steatosis Assessment
por: Shao, Congxiang, et al.
Publicado: (2022)

Distinct Dose-Dependent Association of Free Fatty Acids with Diabetes Development in Nonalcoholic Fatty Liver Disease Patients
por: Li, Fuxi, et al.
Publicado: (2021)

Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction
por: Ye, Junzhao, et al.
Publicado: (2019)

Metabolic benefits of changing sedentary lifestyles in nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials
por: Ma, Qianqian, et al.
Publicado: (2022)

Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study
por: Ye, Junzhao, et al.
Publicado: (2019)

Normalization of γ-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease
por: Ma, Qianqian, et al.
Publicado: (2021)

The Additive Values of the Classification of Higher Serum Uric Acid Levels as a Diagnostic Criteria for Metabolic-Associated Fatty Liver Disease
por: He, Jie, et al.
Publicado: (2022)

Distinct Cause of Death Profiles of Hospitalized Non-alcoholic Fatty Liver Disease: A 10 Years' Cross-Sectional Multicenter Study in China
por: Lin, Yansong, et al.
Publicado: (2021)

Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease
por: Shao, Cong xiang, et al.
Publicado: (2021)

Impact of skeletal muscle mass evaluating methods on severity of metabolic associated fatty liver disease in non-elderly adults
por: Zhou, Ting, et al.
Publicado: (2023)

Dynamic monitoring with shear wave elastography predicts outcomes of chronic hepatitis B patients with decompensated cirrhosis
por: Ye, Junzhao, et al.
Publicado: (2021)

Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease
por: Dogru, Teoman, et al.
Publicado: (2014)

Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
por: Lei, Fang, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
por: Kim, Eun Jeong, et al.
Publicado: (2019)

Prevalence and Significance of Antinuclear Antibodies in Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Luo, Ling, et al.
Publicado: (2022)

Metabolomic Profiles of Nonobese and Obese Women With Gestational Diabetes
por: Sormunen-Harju, Heidi, et al.
Publicado: (2023)

Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects
por: Zhang, Shujun, et al.
Publicado: (2017)

Alterations in Circulating Bile Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis
por: Lai, Jiaming, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis
por: Sinn, Dong Hyun, et al.
Publicado: (2016)

Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease
por: Arvind, Ashwini, et al.
Publicado: (2021)

Untargeted metabolomics characteristics of nonobese nonalcoholic fatty liver disease induced by high-temperature-processed feed in Sprague-Dawley rats
por: Xue, Li-Jun, et al.
Publicado: (2020)

Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes
por: Lin, Yansong, et al.
Publicado: (2022)

Subclinical thyroid dysfunction and risk of carotid atherosclerosis
por: Kim, Hosu, et al.
Publicado: (2017)

Nonalcoholic fatty liver disease as an independent risk factor for carotid atherosclerosis
por: Rasool, Abid, et al.
Publicado: (2017)

Ventricular Dysfunction in Obese and Nonobese Rats with Metabolic Syndrome
por: Torres-Jacome, Julian, et al.
Publicado: (2022)

Identifying the metabolomic fingerprint of high and low flavonoid consumers
por: Ivey, Kerry L., et al.
Publicado: (2017)

Prevalence and Factors Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Korean Population
por: Cho, Hyun Chin
Publicado: (2016)

Multifocal fatty liver disease, insulin resistance and carotid atherosclerosis: exploring the interrelated relationship
por: Hanafy, Amr Shaaban, et al.
Publicado: (2018)

Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease
por: Wang, Baohong, et al.
Publicado: (2016)

The eSS rat, a nonobese model of disordered glucose and lipid metabolism and fatty liver
por: Daniele, Stella M, et al.
Publicado: (2010)

Nonalcoholic Fatty Liver Disease in Nonobese Subjects of African Origin Has Atypical Metabolic Characteristics
por: Thompson, Debbie S, et al.
Publicado: (2019)

Network of Interactions Between Gut Microbiome, Host Biomarkers, and Urine Metabolome in Carotid Atherosclerosis
por: Li, Rui-Jun, et al.
Publicado: (2021)

Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2021)

Association between triglyceride glucose index and carotid intima‐media thickness in obese and nonobese adults
por: Jia, Xiaojing, et al.
Publicado: (2022)

Metabolomic fingerprinting of pig seminal plasma identifies in vivo fertility biomarkers
por: Mateo-Otero, Yentel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0f848ert3hup724jsoqhljghm7